Skip Navigation


Carcinogenesis Advance Access originally published online on September 12, 2008
Carcinogenesis 2009 30(1):106-113; doi:10.1093/carcin/bgn213
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/1/106    most recent
bgn213v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bratton, M. R.
Right arrow Articles by Burow, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bratton, M. R.
Right arrow Articles by Burow, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase

Melyssa R. Bratton1,2,{dagger}, Daniel E. Frigo2,3,4,{dagger}, Katinka A. Vigh-Conrad2,8, Daju Fan4, Scott Wadsworth5, John A. McLachlan1,2 and Matthew E. Burow2,6,7,*

1 Department of Pharmacology
2 Center for Bioenvironmental Research
3 Molecular and Cellular Biology Program, Tulane University Health Science Center, New Orleans, LA 70112, USA
4 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA
5 Johnson & Johnson Pharmaceutical Research & Development, Raritan, NJ 08869-0602, USA
6 Department of Medicine, Section of Hematology and Medical Oncology
7 Department of Surgery, Tulane University Health Science Center, New Orleans, LA 70112, USA
8 Present address: Department of Human Genetics, The University of Chicago, Chicago, IL 60637

* To whom correspondence should be addressed. Department of Medicine, Section of Hematology and Medical Oncology, Tulane University Health Sciences Center, 1430 Tulane Avenue SL-78, New Orleans, LA 70112, USA. Tel: +1 504 988 6688; Fax: +1 504 988 6215; Email: mburow{at}tulane.edu

The activity of nuclear transcription factors is often regulated by specific kinase-signaling pathways. We have previously shown that the organochlorine pesticide dichlorodiphenyltrichloroethane (DDT) stimulates activator protein-1 activity through the p38 mitogen-activated protein kinase (MAPK). Here, we show that DDT and its metabolites also stimulate the transcriptional activity of cyclic adenosine monophosphate response element-binding protein and Elk1 and potentiate gene expression through cyclic adenosine monophosphate and hypoxia response elements. Because DDT stimulates gene expression through various transcription factors and hence multiple response elements, we hypothesized that p38 signaling targets a common shared transcriptional activator. Here, we demonstrate using both pharmacological and molecular techniques, the general coactivator p300 is phosphorylated and potentiated by the p38 MAPK signaling cascade. We further show that p38 directly phosphorylates p300 in its N-terminus. These results, together with our previous work, suggest that p38 stimulates downstream transcription factors in part by targeting the general coactivator p300.

Abbreviations: AP-1, activator protein-1; CA-MKK, constitutively active mitogen-activated protein kinase kinase; cDNA, complementary DNA; CREB, cyclic adenosine monophosphate response element binding; DDT, dichlorodiphenyltrichloroethane; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl sulfoxide; DN, dominant negative; ER, estrogen receptor; ERK, extracellular-signal regulated kinase; FBS, fetal bovine serum; GST, glutathione S-transferase; HEK, human embryonic kidney; MAPK, mitogen-activated protein kinase; MPA, tetradecanoyl-13-phorbol acetate


{dagger} These authors contributed equally to this work and should both be considered first authors.

Received July 21, 2008; revised August 28, 2008; accepted September 1, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
M. Porta, T. Lopez, J. Pumarega, M. Jariod, M. Crous-Bou, E. Marco, J. Rifa, J. O. Grimalt, N. Malats, F. X. Real, et al.
In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations
Mutagenesis, November 1, 2009; 24(6): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. King, N. S. Holden, W. Gong, C. F. Rider, and R. Newton
Inhibition of NF-{kappa}B-dependent Transcription by MKP-1: TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK
J. Biol. Chem., September 25, 2009; 284(39): 26803 - 26815.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.